CTX Platforms

Targeted Technology for Cancer Therapy and Diagnostics

Health Tech & Life Sciences
Non Active, Jul 2023 ceased to operate
Pre-Funding Be'er Sheva, Israel Founded 2018
LinkedIn
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2018
Headcount
1
HQ
Be'er Sheva, Israel
Sector
Health Tech & Life Sciences

About

CTX Platforms is a biotechnology company rapidly advancing towards a disruptive targeted technology application for imaging and treatment of brain cancers and other non-CNS tumors.

The company is developing a theranostic system, potentially capable of imaging living brain tumors and treating brain cancer in children and adults with non-invasive magnetic fields heating technology. This novel technology is based on the sophisticated delivery of magnetic nanoparticles directly to their location in the brain and the induction of focal heat to destroy the cancer cells. Together with existing immunotherapy, this adjuvant treatment can potentially offer new hope for people with GBM.

CTX develops its proprietary particles under license from cutting edge technology and academic centers.

Q&A

What is the current operational status of CTX Platforms?
CTX Platforms is currently inactive, having ceased operations in July 2023.
What is CTX Platforms' primary focus?
CTX Platforms is a biotechnology company focused on developing targeted technology for cancer therapy and diagnostics, specifically for imaging and treatment of brain cancers and other non-CNS tumors.
When was CTX Platforms founded?
CTX Platforms was founded in March 2018.
How many employees does CTX Platforms have?
CTX Platforms has 1-10 employees.
What is the current funding stage of CTX Platforms?
CTX Platforms is currently in the Pre-Funding stage.
Who are the founders of CTX Platforms?
The co-founders of CTX Platforms are Omer Porat, who serves as CEO, and Hagay Shmuely, who is no longer with the company.
What is the core technology CTX Platforms is developing?
CTX Platforms is developing a theranostic system that uses magnetic nanoparticles and non-invasive magnetic fields heating technology to image and treat brain tumors.
Does CTX Platforms hold any patents?
Yes, CTX Platforms holds 1 patent.

Team · 2

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-founder (No longer with the company)
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticalsHealthcarePatientsProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

pharmaceuticalsdiagnosticsbiopharmaceuticalcancerimagingimmuno-theraphytherapeuticsmedical-equipmenttargetingoncologyhealthcare-providerspharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

LinkedInlinkedin.com/company/29749349

Identifiers & details

Founded2018-3
Employees (exact)1
Status reasonNon Active, Jul 2023 ceased to operate